Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Rheumatic Disease Center (RDC) is a leading independent rheumatology practice and clinical research organization based in southeastern Wisconsin. Established in 1972, it is the oldest and largest specialty clinic of its kind in the region, providing comprehensive care for patients with complex autoimmune and inflammatory conditions. RDC operates a dedicated Clinical Research Center that serves as a key site for Phase 2 through Phase 4 clinical trials, collaborating with major pharmaceutical sponsors such as AbbVie, Eli Lilly, and Janssen. The center integrates advanced diagnostics, including musculoskeletal ultrasound and DEXA scans, with a fully staffed infusion therapy center for the administration of biologic treatments. RDC's mission focuses on delivering individualized, state-of-the-art medical care while advancing the field of rheumatology through active participation in global drug development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rheumatic Disease Center.